IDT and Aldevron launch Cas9 mRNA for CRISPR gene editing research

Go back to IDT and Aldevron launch Cas9 mRNA for CRISPR gene editing research

Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development

September 16, 2026 8:03 AM EDT

Co-developed offering connects Integrated DNA Technologies CRISPR engineering and analysis expertise with Aldevrons mRNA manufacturing capabilities, helping customers move from discovery toward clinical development with greater speed, continuity, and confidence.Research grade S.p. Cas9 mRNA is available in wild type and SpyFi high-fidelity formats to support CRISPR-based research applications.Optimized mRNA constructs are designed for high on-target editing, reduced off-target activity with SpyFi, low toxicity, and delivery method flexibility.

FARGO, N.D. & CORALVILLE, Iowa--(BUSINESS WIRE)-- Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics,... More